Cary Street Partners’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$12.4M Sell
56,179
-122
-0.2% -$33.7K 0.27% 89
2026
Q1
$16.6M Sell
56,301
-106
-0.2% -$31.5K 0.41% 57
2025
Q4
$15.4M Buy
56,407
+145
+0.3% +$39.4K 0.38% 61
2025
Q3
$15.2M Sell
56,262
-555
-1% -$151K 0.39% 59
2025
Q2
$15.7M Sell
56,817
-3,952
-7% -$1.07M 0.44% 55
2025
Q1
$16.1M Sell
60,769
-1,059
-2% -$261K 0.51% 48
2024
Q4
$14.4M Buy
+61,828
New +$14.2M 0.47% 55

Other funds holding CME

Cary Street Partners's CME Position: Q2 2026 in Review

Cary Street Partners reduced its CME Group (CME) stake by 0.22% in Q2 2026, selling an estimated $33.7K and leaving 56,179 shares worth $12.4M. The position accounts for 0.27% of the portfolio, ranked #89.

Cary Street Partners first reported a position in CME in Q4 2024 and has held it in 7 quarters since. The position peaked at $16.6M in Q1 2026. 1,694 funds tracked by Wall St. Rank hold CME as of Q2 2026.

  • Cary Street Partners held 56,179 shares of CME Group worth $12.4M as of Q2 2026.
  • Cary Street Partners sold 122 CME Group shares in Q2 2026, an estimated $33.7K.
  • CME Group made up 0.27% of Cary Street Partners's portfolio in Q2 2026, its #89 holding.
  • Cary Street Partners first reported a position in CME Group in Q4 2024 and has held it in 7 quarters since.
  • Cary Street Partners's CME Group position peaked at $16.6M in Q1 2026.
  • 1,694 funds tracked by Wall St. Rank held CME Group as of Q2 2026.

Based on Cary Street Partners's 13F filing for Q2 2026, filed 17 Jul 2026.